The decision was issued this afternoon.
Europe's health regulator's approved the use of the Moderna Covid vaccine for 12 to 17 year olds.
The vaccine is already approved for those aged 18 and over.
It follows a trial involving more than 3,700 children.
The study showed the vaccine produced a comparable antibody response in teens and adolescents to that seen in young adults.
EMA has just approved the #COVID19vaccine Spikevax, previously known as COVID-19 Vaccine Moderna, for children aged 12 to 17 in the 🇪🇺.
— EU Medicines Agency (@EMA_News) July 23, 2021
👉https://t.co/pnxvNYXDBH pic.twitter.com/WZgUz7G19K
